Cargando…
A Recombinant Parathyroid Hormone‐Related Peptide Locally Applied in Osteoporotic Bone Defect
The local application of drug‐loaded bioactive scaffold materials is one of the important directions to solve the clinical problem of osteoporotic (OP) bone defects. This study retains the advantages of drug loading and mechanical properties of natural 3D bioactive scaffolds. The scaffolds are funct...
Autores principales: | Wang, Yi, Hu, Yingkun, Lan, Shenghui, Chen, Zhe, Zhang, Yufeng, Guo, Xiaodong, Cai, Lin, Li, Jingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401080/ https://www.ncbi.nlm.nih.gov/pubmed/37229774 http://dx.doi.org/10.1002/advs.202300516 |
Ejemplares similares
-
Hydrogel-based delivery system applied in the local anti-osteoporotic bone defects
por: Gong, Yining, et al.
Publicado: (2022) -
Intermittent Parathyroid Hormone Alters Gut Microbiota in Ovariectomized Osteoporotic Rats
por: Zhou, Jiaming, et al.
Publicado: (2022) -
Efficacy of Recombinant Human Parathyroid Hormone versus Vertebral Augmentation Procedure on Patients with Acute Osteoporotic Vertebral Compression Fracture
por: Gou, Pengguo, et al.
Publicado: (2022) -
Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival
por: Almadori, Giovanni, et al.
Publicado: (2022) -
Effects of Intermittent Parathyroid Hormone 1–34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women
por: Tang, Yutao, et al.
Publicado: (2019)